Biotech SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares June 17, 2026
Biotech PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING June 16, 2026
Biotech Lundbeck presents new Phase II asedebart data in Cushing’s disease at ENDO 2026 June 15, 2026
Biotech Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting June 14, 2026
Biotech Beyond the Double Helix: Phinomics Joins “All Access hosted by Andy Garcia” to Explore Hidden Frontiers in Genetics June 12, 2026
Biotech Roche’s VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies June 11, 2026
Biotech Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders June 10, 2026
Biotech IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants June 9, 2026
Biotech Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma) June 8, 2026
Search
Biotech
June 17, 2026
June 16, 2026
June 15, 2026
June 14, 2026
June 13, 2026
June 12, 2026
June 11, 2026
June 10, 2026
June 9, 2026
June 8, 2026
